Stocks and Investing Stocks and Investing
Wed, June 2, 2021
Tue, June 1, 2021
Fri, May 28, 2021
Thu, May 27, 2021
Wed, May 26, 2021

Drew Ranieri Maintained (TMCI) at Hold with Increased Target to $32 on, May 26th, 2021


Published on 2024-10-27 16:48:40 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Hold with Increased Target from $30 to $32 on, May 26th, 2021.

Drew has made no other calls on TMCI in the last 4 months.



There are 3 other peers that have a rating on TMCI. Out of the 3 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Drew


  • Richard Newitter of "SVB Leerink" Initiated at Buy and Held Target at $38 on, Monday, May 24th, 2021
  • Rick Wise of "Stifel" Initiated at Strong Buy and Held Target at $35 on, Tuesday, May 18th, 2021
  • Robbie Marcus of "JP Morgan" Initiated at Buy and Held Target at $37 on, Tuesday, May 18th, 2021